Fagan Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,345
Closed -$831K 125
2024
Q4
$831K Sell
7,345
-175
-2% -$20.2K 0.13% 82
2024
Q3
$857K Hold
7,520
0.14% 82
2024
Q2
$781K Sell
7,520
-100
-1% -$10.6K 0.14% 78
2024
Q1
$866K Sell
7,620
-10
-0.1% -$1.15K 0.16% 79
2023
Q4
$840K Sell
7,630
-100
-1% -$9.99K 0.18% 70
2023
Q3
$749K Sell
7,730
-17
-0.2% -$1.78K 0.18% 71
2023
Q2
$845K Hold
7,747
0.2% 70
2023
Q1
$784K Hold
7,747
0.2% 75
2022
Q4
$851K Sell
7,747
-75
-1% -$7.77K 0.23% 72
2022
Q3
$757K Hold
7,822
0.21% 72
2022
Q2
$850K Sell
7,822
-8
-0.1% -$909 0.23% 70
2022
Q1
$927K Sell
7,830
-100
-1% -$12.4K 0.19% 76
2021
Q4
$1.12M Buy
7,930
+5
+0.1% +$640 0.21% 73
2021
Q3
$936K Hold
7,925
0.2% 74
2021
Q2
$919K Sell
7,925
-210
-3% -$24.5K 0.2% 76
2021
Q1
$975K Sell
8,135
-650
-7% -$77K 0.23% 74
2020
Q4
$962K Sell
8,785
-55
-0.6% -$5.98K 0.24% 66
2020
Q3
$962K Buy
8,840
+355
+4% +$36K 0.28% 62
2020
Q2
$776K Buy
8,485
+485
+6% +$43.8K 0.25% 67
2020
Q1
$631K Buy
8,000
+505
+7% +$42.1K 0.25% 66
2019
Q4
$651K Sell
7,495
-100
-1% -$8.38K 0.21% 80
2019
Q3
$635K Buy
7,595
+100
+1% +$8.5K 0.25% 75
2019
Q2
$630K Sell
7,495
-75
-1% -$5.9K 0.26% 79
2019
Q1
$605K Hold
7,570
0.26% 77
2018
Q4
$548K Hold
7,570
0.28% 77
2018
Q3
$555K Hold
7,570
0.23% 85
2018
Q2
$462K Buy
7,570
+50
+0.7% +$3.03K 0.21% 87
2018
Q1
$451 Sell
7,520
-50
-0.7% -$3.01K 0.19% 82
2017
Q4
$432 Buy
7,570
+285
+4% +$15.8K 0.17% 89
2017
Q3
$389K Buy
7,285
+385
+6% +$19.3K 0.19% 89
2017
Q2
$335K Buy
+6,900
New +$312K 0.17% 92

Other funds holding ABT

Fagan Associates's ABT Position: Q1 2025 in Review

Fagan Associates sold out of Abbott (ABT) in Q1 2025, closing a stake of 7,345 shares — an estimated $831K sold.

Fagan Associates first reported a position in ABT in Q2 2017 and held it in 31 quarters. The position peaked at $1.12M in Q4 2021. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

  • Fagan Associates reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
  • Fagan Associates sold 7,345 Abbott shares in Q1 2025, an estimated $831K.
  • Fagan Associates first reported a position in Abbott in Q2 2017 and held it in 31 quarters.
  • Fagan Associates's Abbott position peaked at $1.12M in Q4 2021.
  • 3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Fagan Associates's 13F filing for Q1 2025, filed 6 May 2025.